These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 35881895)
1. Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 - a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein-like Receptor 1- on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction. Van Tassell BW; Wohlford GF; Del Buono MG; Damonte JI; Markley R; Turlington J; Kadariya D; Talasaz A; Ho J; Marawan A; Thomas GK; Austin D; Gineste C; Gelber C; Abbate A J Cardiovasc Pharmacol; 2022 Nov; 80(5):672-678. PubMed ID: 35881895 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction). Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B; Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990 [TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944 [TBL] [Abstract][Full Text] [Related]
4. Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction. Chen WR; Chen YD; Tian F; Yang N; Cheng LQ; Hu SY; Wang J; Yang JJ; Wang SF; Gu XF Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940956 [TBL] [Abstract][Full Text] [Related]
5. 1-Year Outcomes of Delayed Versus Immediate Intervention in Patients With Transient ST-Segment Elevation Myocardial Infarction. Janssens GN; van der Hoeven NW; Lemkes JS; Everaars H; van de Ven PM; Marques KMJ; Nap A; van Leeuwen MAH; Appelman Y; Knaapen P; Verouden NJW; Allaart CP; Brinckman SL; Saraber CE; Plomp KJ; Timmer JR; Kedhi E; Hermanides RS; Meuwissen M; Schaap J; van der Weerdt AP; van Rossum AC; Nijveldt R; van Royen N JACC Cardiovasc Interv; 2019 Nov; 12(22):2272-2282. PubMed ID: 31488353 [TBL] [Abstract][Full Text] [Related]
6. Short-term efficacy of angiotensin receptor-neprilysin inhibitor treatment in patients with ST-segment elevation myocardial infarction with reduced ejection fraction after primary percutaneous coronary intervention: a propensity score matching study. Zhang Q; Qiao B; Han Y; Sun S; Wang B; Wei S BMC Cardiovasc Disord; 2022 Nov; 22(1):463. PubMed ID: 36333668 [TBL] [Abstract][Full Text] [Related]
7. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial. Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794 [TBL] [Abstract][Full Text] [Related]
8. Inhibiting the Inflammatory Injury After Myocardial Ischemia Reperfusion With Plasma-Derived Alpha-1 Antitrypsin: A Post Hoc Analysis of the VCU-α1RT Study. Abouzaki NA; Christopher S; Trankle C; Van Tassell BW; Carbone S; Mauro AG; Buckley L; Toldo S; Abbate A J Cardiovasc Pharmacol; 2018 Jun; 71(6):375-379. PubMed ID: 29634656 [TBL] [Abstract][Full Text] [Related]
9. Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B. Bonaca MP; Morrow DA; Bergmark BA; Berg DD; Lima JAC; Hoffmann U; Kato Y; Lu MT; Kuder J; Murphy SA; Spinar J; Oude Ophuis T; Kiss RG; Lopez-Sendon J; Averkov O; Wheatcroft SB; Kubica J; Carlos Nicolau J; Furtado RHM; Abuhatzira L; Hirshberg B; Omar SA; Vavere AL; Chang YT; George RT; Sabatine MS Circulation; 2022 Sep; 146(12):907-916. PubMed ID: 36039762 [TBL] [Abstract][Full Text] [Related]
10. Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial. Le Corvoisier P; Gallet R; Lesault PF; Audureau E; Paul M; Ternacle J; Ghostine S; Champagne S; Arrouasse R; Bitari D; Mouillet G; Dubois-Randé JL; Berdeaux A; Ghaleh B; Deux JF; Teiger E BMC Cardiovasc Disord; 2018 Oct; 18(1):193. PubMed ID: 30340532 [TBL] [Abstract][Full Text] [Related]
11. Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial. Eppinga RN; Hartman MH; van Veldhuisen DJ; Lexis CP; Connelly MA; Lipsic E; van der Horst IC; van der Harst P; Dullaart RP PLoS One; 2016; 11(1):e0145719. PubMed ID: 26808474 [TBL] [Abstract][Full Text] [Related]
12. [Impact of inflammatory reaction levels and culprit plaque characteristics on preprocedural thrombolysis in myocardial infarction flow grade in patients with ST-segment elevation myocardial infarction]. Wang JF; Fang C; Yang G; Lu J; Zhang ST; Li LL; Liu HM; Xu ME; Ren XF; Ma LJ; Yu H; Wei G; Hou JB; Yang S; Dai JN; Yu B Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Feb; 49(2):150-157. PubMed ID: 33611901 [No Abstract] [Full Text] [Related]
13. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy. Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010 [TBL] [Abstract][Full Text] [Related]
14. [The prognostic value of myocardial infarct size measured by cardiovascular magnetic resonance in patients with acute ST-segment elevation myocardial infarction]. Zhang SR; Li RX; Jiao YD; Zhang N; Duan WL; Sun ZJ; Sun ZQ Zhonghua Nei Ke Za Zhi; 2021 Aug; 60(8):751-756. PubMed ID: 34304452 [No Abstract] [Full Text] [Related]
15. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention. Roolvink V; Ibáñez B; Ottervanger JP; Pizarro G; van Royen N; Mateos A; Dambrink JE; Escalera N; Lipsic E; Albarran A; Fernández-Ortiz A; Fernández-Avilés F; Goicolea J; Botas J; Remkes W; Hernandez-Jaras V; Kedhi E; Zamorano JL; Navarro F; Alfonso F; García-Lledó A; Alonso J; van Leeuwen M; Nijveldt R; Postma S; Kolkman E; Gosselink M; de Smet B; Rasoul S; Piek JJ; Fuster V; van 't Hof AWJ; J Am Coll Cardiol; 2016 Jun; 67(23):2705-2715. PubMed ID: 27050189 [TBL] [Abstract][Full Text] [Related]
16. High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention. Du Y; Zhao Y; Zhu Y; Hu C; Zhang J; Ji Q; Liu W; Han H; Yang L; Zhang D; Tong S; Wang Z; Guo Y; Liu X; Zhou Y J Atheroscler Thromb; 2019 Oct; 26(10):868-878. PubMed ID: 30773518 [TBL] [Abstract][Full Text] [Related]
17. Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol - The COVERT-MI Study. Bresson D; Roubille F; Prieur C; Biere L; Ivanes F; Bouleti C; Dubreuil O; Rioufol G; Boutitie F; Sideris G; Elbaz M; Bochaton T; De Bourguignon C; El Jonhy N; Dufay N; Dhelens C; Croisille P; Prunier F; Angoulvant D; Ovize M; Maucort-Boulch D; Mewton N Cardiology; 2021; 146(2):151-160. PubMed ID: 33582664 [TBL] [Abstract][Full Text] [Related]
18. Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial. Limalanathan S; Andersen GØ; Kløw NE; Abdelnoor M; Hoffmann P; Eritsland J J Am Heart Assoc; 2014 Apr; 3(2):e000679. PubMed ID: 24760962 [TBL] [Abstract][Full Text] [Related]
19. The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality. Hartman MHT; Eppinga RN; Vlaar PJJ; Lexis CPH; Lipsic E; Haeck JDE; van Veldhuisen DJ; van der Horst ICC; van der Harst P Clin Cardiol; 2017 May; 40(5):322-328. PubMed ID: 28026027 [TBL] [Abstract][Full Text] [Related]
20. [Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention]. Li S; Fu X; Dai Y; Liu C; Wang Y; Li W; Wu W; Gu X; Hao G; Fan W; Miao Q; Jiang Y Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Nov; 43(11):954-9. PubMed ID: 26888806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]